MF
Therapeutic Areas
ClearPoint Neuro Pipeline
| Drug | Indication | Phase |
|---|---|---|
| ClearPoint Platform (Maestro Software, SmartFlow Cannula) | Surgical Navigation & Delivery for CNS disorders | Commercial |
| Gene Therapy Infusion Coverage Tool | Software for modeling drug infusion distribution in the brain | Development |
| Automatic Subnuclei Segmentation | Enhanced targeting for Deep Brain Stimulation (DBS) | Development |
| Radially Branching Intra-Cerebral Delivery Device | Delivery of stem cells and gene therapy vectors | Pre-clinical |
Leadership Team at ClearPoint Neuro
JB
Joseph Burnett
President & Chief Executive Officer
DD
Danilo D’Alessandro
Chief Financial Officer
MS
Mazin Sabra
Chief Operations Officer
JS
Jeremy Stigall
Chief Business Officer
PS
Paul S. Larson, MD, FAANS
Chief Medical Officer
EC
Ellisa Cholapranee
General Counsel
LZ
Lyubomir Zagorchev, PhD
Vice President of Clinical Science & Applications
MM
Mary McNamara-Cullinane
Senior Vice President of Regulatory Affairs
ES
Ernesto Salegio, PhD
Vice President, Segment Leader Translational & Pre-Clinical Research
TO
Timothy Orr
Vice President of Software Development